Pharmacogenomic screening for anthracycline-induced cardiotoxicity in childhood cancer

Br J Clin Pharmacol. 2017 May;83(5):1143-1145. doi: 10.1111/bcp.13218. Epub 2017 Mar 19.
No abstract available

Keywords: anthracycline; anthracycline-induced cardiotoxicity; cancer; chemotherapy; clinical practice guidelines; congestive heart failure; pharmacogenomic screening.

Publication types

  • Letter
  • Comment

MeSH terms

  • Anthracyclines
  • Antibiotics, Antineoplastic
  • Cardiotoxicity*
  • Humans
  • Neoplasms
  • Pharmacogenomic Testing*

Substances

  • Anthracyclines
  • Antibiotics, Antineoplastic